357
Views
81
CrossRef citations to date
0
Altmetric
Original

Modulation Of Inflammatory Mediators By Ibuprofen And Curcumin Treatment During Chronic Inflammation In Rat

, , , &
Pages 213-224 | Published online: 28 Apr 2003

References

  • Kuby J. Leukocyte migration and inflammation. Immunology. 2nd Ed., W.H. Freman and Company, New York 1997; 357–378
  • Cush J.J., Lipsky P.E. Cellular basis for rheumatoid inflammation. Clin. Orthop. 1991; 265: 9–22
  • Cush J.J., Lipsky P.E. The immunopathogenesis of rheumatoid arthritis: the role of cytokines in chronic inflammation. Clin. Asp. Autoimmune 1987; 1: 2–12
  • Harris E.D. Rheumatoid arthritis: pathophysiology and implication for treatment. New. Engl. J. Med. 1990; 322: 1277–1289
  • Ziff M. Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum. 1974; 17: 313–319
  • Schumacher H.R., Kitridou R.C. Synovitis of recent onset: a clincopathologic study during the first month of the disease. Arthritis Rheum. 1972; 15: 465–485
  • Pearson C.M. Experimental joint disease observations on adjuvant induced arthritis. J. Chronic Dis. 1963; 16: 836–874
  • Cush J.J., Lipsky P.E. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum. 1988; 31: 1230–1238
  • Van B., Paget S.A. Predominantly T-cell infiltrate in rheumatoid synovial membranes. New. Engl. J. Med. 1975; 293: 517–520
  • Odeh M. Role of cytokines in rheumatoid arthritis. Drugs News Perspect. 1998; 11: 331–341
  • Appleton I., Tomlinson A., Derek A.W. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 1996; 35: 27–78
  • Herlin T., Fogh K., Hansen E.S., Andreasen A., Knudsen V., Henriksen T.B., Bunger C., Kragballe K. 15-HETE inhibits Leukotriene B4 formation and synovial cell proliferation in experimental arthritis. Agents Action 1990; 29: 52–53
  • Kushnar I., Mackiewiez A. Acute phase proteins as disease markers. Dis. Marker 1987; 5: 1–11
  • Badolato R., Oppenhein J.J. Role of cytokines, acute-phase proteins and chemokines in the progression of rheumatoid arthritis. Semin. Arthritis Rheum. 1996; 26: 526–538
  • Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990; 265: 621–636
  • Srimal R.C. Turmeric: a brief review of medicinal properties. Fitoterapia 1997; L X VIII: 483–493
  • Kantor T.G. Ibuprofen. Ann. Intern. Med. 1979; 91: 877–882
  • Otterness I.G., Bliven M.N. Laboratory models for testing non steroidal anti inflammatory drugs. Chem. Pharmacol. Drugs 1985; 5: 111–252
  • Walz D.T., Dimartino M.J., Misher A. Adjuvant induced arthritis in rats II. drug effects on physiologic, biochemical and immunological parameters. J. Pharmacol. Exp. Ther. 1971; 178: 223–231
  • Mazzon E., Serraino I., Li J.H., Dubo I., Caputi A.P., Zhang J., Cuzzocrea S. GPI 6150 a Poly (ADP ribose) polymerase inhibitor exhibits an anti- inflammatory effect in rat models of inflammation. Eur. J. Pharmacol. 2001; 415: 85–94
  • Thieme T.R., Mirkovich A., Maloney P., Goodwyn D.A. In vivo and vitro effects of dexamethasone on leukocyte migration in the rat adjuvant arthritis model. Inflammation 1982; 6: 371–386
  • Wilson J.L., Carmody J.J., Walker J.S. The importance of the hypothalamo-hypophyseal- adrenal axis to the anti-inflammatory actions of the κ-opioid agonist PNU-50, 488H in rats with adjuvant arthritis. J. Pharmacol. Exp. Ther. 2000; 294: 1131–1136
  • Anderson G.D., Hauser S.D. Selective inhibition of cycloxygenase (COX-2) reverses inflammation and expression of COX-2 and IL-6 in rat adjuvant arthritis. J. Clin. Invest. 1996; 97: 2672–2679
  • Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996; 14: 397–440
  • Brennan F.M., Chantry D., Jackson A., Maini R., Feldmann M. Inhibitory effect of TNF-α antibodies on synovial cell Interleukin-1 production in rheumatoid arthritis. Lancet 1989; 2: 244–247
  • John H.S., Anderle S.K., Brown R.R., Dalldorf F.G., Thomson R.C. Pro and anti-inflammatory roles of Interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect. Immun. 1991; 59: 4436–4442
  • Cominelli F., Nast C.C., Llerena R., Dinarello C.A., Zipser R.D. Interleukin-1 suppresses inflammation in rabit colitis. J. Clin. Invest. 1990; 85: 582–587
  • Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem. 1994; 63: 175–195
  • Ialenti A., Moncada S., Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br. J. Pharmacol. 1993; 110: 701–705
  • Connor J.R., Manning P.T., Settle S.L., Moore W.M., Jerome G.M., Webber R.K., Tjoeng F.S., Currie M.G. Suppression of adjuvant induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol. 1995; 273: 15–24
  • Francis M., Allen J.B., Mizel D.E., Allrina J.E., Xie Q., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitor of NOS. J. Exp. Med. 1993; 178: 749–754
  • Nathan C. Inducible nitric oxide synthase: what difference does it make?. J. Clin. Invest. 1997; 100: 2417–2423
  • Connelly L., Pallacios-Callender M., Ameixa C., Moncada S., Hobbs A.J. Biphasic regulation of NF-κB activity underlies the pro and anti inflammatory actions of nitric oxide. J. Immunol. 2001; 166: 3873–3881
  • Whicher J.T., Dieppe P.A. Acute phase proteins. Clin. Immonol. Allergy 1985; 5: 425–446
  • De Witt D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochem. Biophys. Acta 1991; 1083: 121–134
  • Herlin T., Fogh K., Edward H., Hansen E.S., Knudsen V.E., Holm I., Kragballe K., Bunger C. Change in lipoxygenase products from synovial fluid in carrageenan induced arthritis in dogs. Acta Pathol. Micrpbiol. Immunol. Scand. 1988; 96: 601–604
  • Martin S.W., Stevens A.J., Brennan B.S., Davies D., Rowland M.M., Houston J.B. Six day old air pouch model of inflammation. J. Pharmacol. Toxicol. Methods 1994; 32: 139–147
  • Mitchel J.A., Axarasereenont P., Thiemermann C., Flower R.J., Vane J.R. Selectivity of non steroidal anti inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl Acad. Sci. USA 1993; 90: 11693–11697
  • Huang M.T., Lysz T., Ferraro T., Abide T.F., Kaskin J.D., Conney A.H. Inhibitory effects of Curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 1991; 51: 813–819
  • Singh S., Aggarwal B.B. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 1995; 270: 24995–25000
  • Brouet I., Ohsim H. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Comm. 1995; 206: 533–540
  • Aeberhard E.E., Henderson S.A., Arabolos N.S., Griscavage J.M., Castro F.E., Barrett C.T., Ignaro L.J. Nonsteroidal anti inflammatory drugs inhibit expression of the inducible NOS gene. Biochem. Biophys. Res. Commun. 1995; 208: 1053–1060
  • Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956–959

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.